ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
30 Aug 2023

Invitation to presentation of Acarix´s second quarter earnings report

Acarix, a leader in acoustic and AI-based cardiac diagnostics, will publish its second quarter results on Thursday 31 August 2023 08:00...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
29 Aug 2023

First Veterans Affairs Healthcare System Standardizes Use of Acarix CADScor System

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a significant advancement in the utilization of its CADS...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
28 Aug 2023

Acarix welcomes Dr. Deepak R. Talreja MD as new Medical Advisor

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of Dr. Deepak R. Talreja, MD, as new Med...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
23 Aug 2023

Acarix to participate in Erik Penser Bank’s Company Day on August 24, 2023

Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce participation in the upcoming Erik Penser Bank Co...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
09 Jun 2023

Announcement from Acarix’s extra general meeting

The extra general meeting of Acarix AB (the "Company") was held today on 9 June 2023 and the following resolutions were passed by the m...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
22 May 2023

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby invited to the extra general meeting to be held on Fri...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
22 May 2023

Acarix raises approximately SEK 22 million through exercise of warrants and resolves on a directed share issue

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
17 May 2023

State-of-the-Art Cardiology Clinic enhances patient care with CADScor System

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today that Abo-Auda Associates Cardiologists in Texoma, Texas ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
16 May 2023

Acarix Awarded Business Sweden 2023 Catalyst Program Award

Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce they have been awarded the 2023 Catalyst Program ...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
11 May 2023

Announcement from Acarix’s annual general meeting

The annual general meeting 2023 ("AGM") of Acarix AB ("Acarix" or the "Company") was held today on 11 May 2023 in Stockholm and the fol...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q1, Regulatory, Report
November 18, 2024
11 May 2023

Acarix AB (publ) publishes Interim Report, January – March 2023

2023 is off to a good startIn the first quarter of 2023 our strategy delivered important results with a breakthrough order from the lar...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
10 May 2023

Invitation to presentation of Acarix´s first quarter report

Acarix will publish its first quarter results on Thursday 11 May 2023 at 08.00 am (CEST). A live webcast will be held at 14.00 (CEST) t...
Continue reading
  • «
  • ‹
  • 7
  • 8
  • 9
  • 10
  • 11
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.